IAF, LLC - 29 Dec 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role: Member of 10% owner group
Signature: /s/ Edward Bennett, Authorized Signatory for IAF, LLC
Issuer symbol: CMRA on OTC
Transactions as of: 29 Dec 2023
Net transactions value: +$210,000
Form type: 4
Filing time: 05 Jan 2024, 17:59:14 UTC
Previous filing: 05 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRA	12.0% Senior Secured Convertible Notes	Purchase	$210,000				$210,000	29 Dec 2023	Common Stock	3,818,181	$0.0550	Direct	F1
transaction	CMRA	Warrants to Purchase Common Stock	Purchase	$0	+7,636,362		$0.000000	7,636,362	29 Dec 2023	Common Stock	7,636,362	$0.0550	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which the reporting person acquired (i) $210,000 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 7,636,362 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.

Content

The reporting person entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which the reporting person acquired (i) $210,000 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 7,636,362 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.